Full Text
The Full Text of this article is available as a PDF (97.1 KB).
Figure 1 .
The multiple effects of left ventricular (LV) dysfunction.
Figure 2 .
Many different neurohormonal pathways are stimulated following myocardial dysfunction.
Figure 3 .
The SAVE study showed that captopril reduced the rate of myocardial infarction.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Hammermeister K. E., DeRouen T. A., Dodge H. T. Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations. Circulation. 1979 Mar;59(3):421–430. doi: 10.1161/01.cir.59.3.421. [DOI] [PubMed] [Google Scholar]
- Kannel W. B., Ho K., Thom T. Changing epidemiological features of cardiac failure. Br Heart J. 1994 Aug;72(2 Suppl):S3–S9. doi: 10.1136/hrt.72.2_suppl.s3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lonn E. M., Yusuf S., Jha P., Montague T. J., Teo K. K., Benedict C. R., Pitt B. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. Circulation. 1994 Oct;90(4):2056–2069. doi: 10.1161/01.cir.90.4.2056. [DOI] [PubMed] [Google Scholar]
- Pfeffer M. A., Braunwald E., Moyé L. A., Basta L., Brown E. J., Jr, Cuddy T. E., Davis B. R., Geltman E. M., Goldman S., Flaker G. C. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992 Sep 3;327(10):669–677. doi: 10.1056/NEJM199209033271001. [DOI] [PubMed] [Google Scholar]
- Pitt D. ACE inhibitor co-therapy in patients with heart failure: rationale for the Randomized Aldactone Evaluation Study (RALES). Eur Heart J. 1995 Dec;16 (Suppl N):107–110. doi: 10.1093/eurheartj/16.suppl_n.107. [DOI] [PubMed] [Google Scholar]
- Sharpe N., Murphy J., Smith H., Hannan S. Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Lancet. 1988 Feb 6;1(8580):255–259. doi: 10.1016/s0140-6736(88)90347-9. [DOI] [PubMed] [Google Scholar]
- Weber K. T., Brilla C. G. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation. 1991 Jun;83(6):1849–1865. doi: 10.1161/01.cir.83.6.1849. [DOI] [PubMed] [Google Scholar]